Fate Therapeutics (FATE) Preferred Shares (2016 - 2026)
Fate Therapeutics (FATE) reported Preferred Shares of $3000.0 for Q1 2026, little changed on a YoY basis from $3000.0 in Q1 2025, and little changed quarter-over-quarter from $3000.0 in Q4 2025.
Fate Therapeutics (FATE) Preferred Shares (2016 - 2026) Analysis & Trends
Fate Therapeutics has reported Preferred Shares for 11 years, with the latest figure at $3000.0 in Q1 2026.
- For the quarter ending Q1 2026, Preferred Shares changed 0.0% year-over-year to $3000.0; the trailing twelve-month figure through Mar 2026 stood at $3000.0 (changed 0.0% YoY), and the FY2025 full-year result was $3000.0, changed 0.0% from the prior year.
- Preferred Shares for Q1 2026 stood at $3000.0, roughly flat from $3000.0 in the prior quarter.
- The five-year high for Preferred Shares was $3000.0 in Q1 2022, with the low at $3000.0 in Q1 2022.
- Historically, Preferred Shares has averaged $3000.0 across 5 years, with a median of $3000.0 in 2022.
- The largest YoY upside for Preferred Shares was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
- Fate Therapeutics' Preferred Shares stood at $3000.0 in 2022, then changed by 0.0% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025, then changed by 0.0% to $3000.0 in 2026.
- The last three Preferred Shares figures came in at $3000.0 (Q1 2026), $3000.0 (Q4 2025), and $3000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fate Therapeutics | 250.86 Mn | 250.86 Mn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |